Correlation between sPLA2-IIA and phosgene-induced rat acute lung injury

Inhalation Toxicology

Volumn 21, Issue 4, 2009, Pages 374-380

  Chen, Hong Li ^a   Hai, Chun Xu ^a   Liang, Xin ^a   Zhang, Xiao Di ^a   Liu, Riu ^a   Qin, Xu Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSGENE; PHOSPHOLIPASE A2 GROUP II; PHOSPHOLIPASE A2 GROUP IIA; UNCLASSIFIED DRUG; CHEMICAL WARFARE AGENT; INTERLEUKIN 10; MESSENGER RNA; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DISEASE SEVERITY; EXPOSURE; LUNG EDEMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD GAS ANALYSIS; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYMOLOGY; GENETICS; LUNG; LUNG DISEASE; LUNG LAVAGE; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CHEMICAL WARFARE AGENTS; GROUP II PHOSPHOLIPASES A2; INTERLEUKIN-10; LUNG; LUNG DISEASES; MALE; ORGAN SIZE; OXYGEN; PHOSGENE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60849088615     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370802449712     Document Type: Article

References (34)

1. 2 in macrophages during acute lung injury in guinea-pig: Involvement of TNF-α in LPS-induced type-II phospholipase A2 synthesis. J. Immunol. 159:391-400.
2. Attalah, H. L., Wu, Y., Alaoui-El-Azher, M., Thouron, F., Koumanov, K., Wolf, C., Brochard, L., Harf, A., Delclaux, C., and Touqui, L. (2003). Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury. Eur Respir J. 21:1040-1045.
3. Bogdan, C., Vodovotz, Y., and Nathan, C. (1991). Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549-1555.
4. Carroll, J. L., McCoy, D. M., McGowan, S. E., Salome, R. G., Ryan, A. J., and Mallampalli, R. K. (2002). Pulmonary-specific expression of tumor necrosis factor-α alters surfactant lipid metabolism, Am. J. Physiol. Lung Cell Mol. Physiol. 282:L735-L742.
5. Chabot, S., Salez, L., McCormack, F. X., Touqui, L., and Chignard, M. (2003). Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am. J. Respir. Cell Mol. Biol. 28:347-353.
6. Dennis, E. A. (1997). The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1-2.
7. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. (1991). IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
8. Frosolono, M. F., and Currie, W. D. (1985). Response of the pulmonary surfactant system to phosgene. Toxicol. Ind. Health 1:29-35.
9. 2 in oleic acid-induced acute lung injury in rabbits. Am. J. Respir. Crit. Care Med. 160:1292-1302.
10. Furue, S., Mikawa, K., Nishina, K., et al. (2001). Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury:Correlation with lung surfactant protection. Crit. Care Med. 29:719-727.
11. Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., and Velu, T. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
12. Hamm, H., Kroegel, C., and Hohlfeld, J. (1996). Surfactant: A review of its functions and relevance in adult respiratory disorders. Respir. Med. 90:251-270.
13. Jugg, B., Jenner, J., and Rice, P. (1999). The effect of perfluoroisobutene and phosgene on rat lavage fluid surfactant phospholipids. Hum. Exp. Toxicol. 18:659-668.
14. Kim, J. Y., Park, J. S., Strassheim, D., Douglas, I., Diaz del Valle, F., Asehnoune, K., Mitra, S., Kwak, S. H., Yamada, S., Maruyama, I., Ishizaka, A., and Abraham, E. (2005). HMGB1 contributes to the development of acute lung injury after hemorrhage. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L958-L965.
15. Lalani, I., Bhol, K., and Ahmed, A. R. (1997). Interleukin-10: Biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79:469-483.
16. Li, W. L., Hai, C. X., Liang, X., Zhang, X. D., Chen, H. L., Qin, X. J., Liu, R., He, W., Wang, P., and Li, B. (2006). Apoptosis of ATII cells in mice induced by phosgene. Inhal. Toxicol. 18:71-77.
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with Folinphenol reagent. J. Biol. Chem. 193:265-275.
18. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R. (1993). Interleukin-10. Annu. Rev. Immunol. 11:165-90.
19. 2s are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273:14411-14423.
20. Phang, P. T., and Keough, K. M. (1986). Inhibition of pulmonary surfactant by plasma from normal adults and from patients having cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 91:248-251.
21. Radvanyi, F., Jordan, L., Russo-Marie, F., and Bon, C. (1989). A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal. Biochem. 177(1):103-9.
22. Salez, L., Balloy, V., van Rooijen, N., Lebastard, M., Touqui, L., McCormack, F. X., and Chignard, M. (2001). Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. J. Immunol. 166:6376-6382.
23. Schmiedl, A., Krug, N., and Hohlfeld, J. M. (2004). Influence of plasma and inflammatory proteins on the ultrastructure of exogenous surfactant. J. Electron. Microsc. 53:407-416.
24. Sciuto, A. M. (1998). Assessment of early acute lung injury in rodents exposed to phosgene. Arch. Toxicol. 72:283-288.
25. Sciuto, A. M. (2000). Posttreatment with ETYA protects against phosgene-induced lung injury by amplifying the glutathione to lipid peroxidation ratio. Inhal. Toxicol. 12:347-356.
26. Sciuto, A. M., Cascio, M. B., Moran, T. S., and Forster, J. S. 2003. The fate of antioxidant enzymes in bronchoalveolar lavage fluid over 7 days in mice with acute lung injury. Inhal. Toxicol. 15:675-685.
27. Siflinger-Birnboim, A., and Johnson, A. (2003). Protein kinase C modulates pulmonary endothelial permeability: A paradigm for acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 284(3):L435-L451.
28. Standiford, T. J., Strieter, R. M., Lukacs, N. W., and Kunkel, S. L. (1995). Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155:2222-2229.
29. Strieter, R. M., Kunkel, S. L., and Bone, R. C. (1993). Role of tumor necrosis factor-alpha in disease states and inflammation, Crit. Care Med. 21(Suppl 10):S447-S463.
30. 2 in ARDS pathogenesis. Mol. Med. Today, 5:244-249.
31. Touqui, L., and Alaoui-El-Azher, M. (2001). Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:739-754.
32. 2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome. Acta Pharmacol. Sin. 24:1292-1296.
33. Tracey, K. J., and Cerami, A. (1993). Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21(Suppl 10):S415-S422.
34. Vadas, P., Browning, J., Edelson, J., and Pruzanski, W. (1993). Extra-cellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediat., 8:1-30.